(redirected from immunotherapy)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
References in periodicals archive ?
EPD therapy need not replace existing methods of immunotherapy that have been proven to be successful.
Why immunotherapy: Cancer immunotherapy is an important sector in biotechnology that is changing the way many cancers are treated.
Of the 1,000 patients who were evaluated, 860 had experienced a complete response to immunotherapy.
The endpoint concentration identifies not only the antigens to which the patient is allergic, but also the patient's level of sensitivity to them, providing a safe point for the initiation of immunotherapy.
Cancer immunotherapy: tumour-immune system interaction, key immunotherapy technologies and mechanisms of action Tumours, the immune system and their interaction with immunotherapy Key immunotherapy technologies Mechanisms of action of leading cancer immunotherapies Interleukin-2 (IL-2) and interferon-alpha (IFN- ?
Launched to coincide with the kickoff on June 1 of CRI's second annual Cancer Immunotherapy Month, the new site includes powerful video and written stories of patients, told in their own words, of their experiences with cancer immunotherapy and how, in some cases, they were not expecting to survive and thanks to these new treatments are now in remission.
We are proud to support the first large-scale, multi-year study to examine adherence to allergy immunotherapy among patients," said John Roby, Chief Executive Officer of Greer.
New Cancer Immunotherapy Website for Patients and Caregivers to Launch June 1
These preclinical data further underscore the potential advantage of a whole cell immunotherapy such as GVAX that present the immune system with multiple, tumor-specific antigens and activate a robust, broad immune response," stated Peter K.
Food and Drug Administration (FDA) to discuss the previously announced results of Genitope's pivotal Phase 3 clinical trial of MyVax[R] personalized immunotherapy in previously untreated follicular B-cell non-Hodgkin's lymphoma (fNHL) patients, Genitope intends to suspend development of MyVax[R] personalized immunotherapy.
Study Findings Published in The Journal of Allergy and Clinical Immunology Provide Unique Perspective on the Benefits of Allergy Immunotherapy